U.S. markets closed

Masimo Corporation (MASI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
222.00+3.37 (+1.54%)
At close: 4:00PM EDT

Masimo Corporation

52 Discovery
Irvine, CA 92618
United States
949 297 7000
http://www.masimo.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees2,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Joseph E. KianiFounder, CEO & Chairman3.49M198.42M1965
Mr. Micah YoungExec. VP of Fin. & CFO762.48k2.72M1979
Mr. Bilal MuhsinChief Operating Officer1.02M6.48M1981
Dr. Steven J. BarkerChairman of Scientific Advisory Board & Chief Science Officer139.56kN/A1945
Mr. Thomas Samuel McClenahanExec. VP, Gen. Counsel & Corp. Sec.757.63k5.47M1973
Mr. Yongsam LeeExec. VP & Chief Information OfficerN/AN/A1965
Mr. Eli KammermanVP of Bus. Devel. & Investor RelationsN/AN/AN/A
Mr. Jon ColemanPres of Worldwide Sales, Professional Services & Medical AffairsN/AN/A1964
Mr. Anand SampathExec. VP of Operations & Clinical ResearchN/AN/A1966
Mr. Thierry LeclercqExec. VP of Bus. Devel.N/AN/A1956
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. The company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. The company offers coronavirus-2019 response and telehealth solutions; connectivity devices; and nasal high flow ventilation and neuromodulation solutions. The company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, physician offices, long term care facilities, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. Incorporated in 1989, the company is headquartered in Irvine, California.

Corporate Governance

Masimo Corporation’s ISS Governance QualityScore as of June 1, 2021 is 5. The pillar scores are Audit: 5; Board: 8; Shareholder Rights: 4; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.